News
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...
People prescribed GLP-1 agents liraglutide (Saxenda) or semaglutide for weight loss decreased their alcohol intake by almost ...
Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.
Donald Trump has vowed to cut the US’s globally high drug prices by as much as 80 per cent with an executive order that seeks to force other countries to pay more for their medicines.
The pharmaceutical industry’s reaction to President Trump’s executive order on drug prices? It could have been worse.Shares ...
Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...
Shares in Novo Nordisk were up nearly 12% today – hiking its valuation to more than $280 billion – after it reported new clinical data with one of its obesity drug candidates. The new results ...
CVS Health is working to balance all parts of its vertically integrated business under new leadership. CEO David Joyner tells Yahoo Finance he's working to define the company. It's been a good week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results